Skip to main content

Duke receives $62 million for Clinical Research on Antibacterial Resistance

The federal grant comes from the National Institute of Allergy and Infectious Diseases

Investigators at Duke Medicine and the University of California San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, directing the allocation of a $62 million federal grant from the National Institute of Allergy and Infectious Diseases. Vance Fowler, Jr., M.D., MHS, professor of medicine at Duke is co-principal investigator of the network.